2025 annual financial data
NovoCure 2025 Operating margin
Direct answer
Operating margin was -23.47%.
Operating income was -153,800,000 USD and net income was -136,227,000 USD.
Operating cash flow was -49,031,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 655,353,000 USD
- Operating income
- -153,800,000 USD
- Net income
- -136,227,000 USD
- Operating cash flow
- -49,031,000 USD